These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke]. Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222 [TBL] [Abstract][Full Text] [Related]
30. Cerebrolysin: a multi-target drug for recovery after stroke. Brainin M Expert Rev Neurother; 2018 Aug; 18(8):681-687. PubMed ID: 30004268 [TBL] [Abstract][Full Text] [Related]
31. Cerebrolysin for vascular dementia. Chen N; Yang M; Guo J; Zhou M; Zhu C; He L Cochrane Database Syst Rev; 2013 Jan; (1):CD008900. PubMed ID: 23440834 [TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130 [TBL] [Abstract][Full Text] [Related]
34. [Cerebrolysin for acute ischemic stroke]. iganshina LE; Abakumova TR Vestn Ross Akad Med Nauk; 2013; (1):21-9. PubMed ID: 23805635 [TBL] [Abstract][Full Text] [Related]
35. Etrolizumab for induction of remission in ulcerative colitis. Rosenfeld G; Parker CE; MacDonald JK; Bressler B Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011661. PubMed ID: 26630451 [TBL] [Abstract][Full Text] [Related]
36. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis. Tramacere I; Virgili G; Perduca V; Lucenteforte E; Benedetti MD; Capobussi M; Castellini G; Frau S; Gonzalez-Lorenzo M; Featherstone R; Filippini G Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012186. PubMed ID: 38032059 [TBL] [Abstract][Full Text] [Related]
37. Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series. Vester JC; Buzoianu AD; Florian SI; Hömberg V; Kim SH; Lee TMC; Matula C; Poon WS; Sandesc D; von Steinbüchel N; Strilciuc S; Vos PE; von Wild K; Muresanu D Neurol Sci; 2021 Nov; 42(11):4531-4541. PubMed ID: 33620612 [TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial. Poon W; Matula C; Vos PE; Muresanu DF; von Steinbüchel N; von Wild K; Hömberg V; Wang E; Lee TMC; Strilciuc S; Vester JC Neurol Sci; 2020 Feb; 41(2):281-293. PubMed ID: 31494820 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Hristovska AM; Duch P; Allingstrup M; Afshari A Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470 [TBL] [Abstract][Full Text] [Related]